Naproxen Tablet, Delayed Release
Product Images NDC 70954-928

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 70954-928). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-1 (Label 1)

Label for Naproxen Delayed-Release Tablets, USP 375 mg by ANI Pharmaceuticals, Inc. The oral delayed-release tablets come in a container of 100 tablets. The label includes storage instructions, tamper-evident warnings, and a barcode, with the distributor located in Baudette, MN.*

FDA Label Image

Label-2 (Label 2)

Label for Naproxen Delayed-Release Tablets USP, 500 mg strength, oral dosage form. The label indicates 100 tablets per container and is labeled for prescription use only. Distributed by ANI Pharmaceuticals, Inc., with storage and dispensing instructions included. The label features a barcode and issuance date of 06/2024.*

FDA Label Image

Structure (Naproxen)

Chemical structure of naproxen showing its molecular formula C14H14O3 and molecular weight 230.26. The structure includes a methoxy group (CH3O) attached to the naphthalene ring, with notation indicating the R group as a carboxylic acid (-COOH).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.